Evidence map›Paper›PMID 39528323›Full record

Trial reportZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2024

[Efficacy evaluation of extending or switching to tenofovir amibufenamide in patients with chronic hepatitis B: a phase Ⅲ randomized controlled study].

Z H Liu, Q L Jin, Y X Zhang, G Z Gong, G C Wu, L F Yao, X F Wen, Z L Gao, Y Huang, D K Yang and 16 more

Abstract readRandomized Controlled TrialClinical Trial, Phase IIIEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Z H LiuKey Laboratory of Infectious Diseases Research in South China, Ministry of Education, Nanfang Hospital, Southern Medical University, Guangzhou510515, China.
Q L JinThe First Hospital of Jilin University, Changchun130021, China.
Y X ZhangThe First Affiliated Hospital of Xinjiang Medical University, Urumqi830054, China.
G Z GongThe Second Xiangya Hospital of Central South University, Changsha410011, China.
G C WuChongqing University Three Gorges Hospital, Chongqing404000, China.
L F YaoMengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou350025, China.
X F WenLiuzhou People's Hospital, Liuzhou545006, China.
Z L GaoThe Third Affiliated Hospital of Zhongshan University, Guangzhou510630, China.
Y HuangXiangya Hospital of Central South University, Changsha410008, China.
D K YangThe First Affiliated Hospital of Xinxiang Medical University, Xinxiang453100, China.
E Q ChenWest China Hospital of Sichuan University, Chengdu610044, China.
Q MaoThe Southwest Hospital of AMU, Chongqing400038, China.
S D LinAffiliated Hospital of Zunyi Medical University, Zunyi563000, China.
J ShangHenan Provincial People's Hospital, Zhengzhou450003, China.
H Y GongThe Third Xiangya Hospital of Central South University, Changsha410205, China.
L H ZhongThe Fourth Affiliated Hospital of Harbin Medical University, Harbin150001, China.
H F YinThe First Affiliated Hospital of Anhui Medical University, Hefei230022, China.
F M WangTianjin Third Central Hospital, Tianjin300170, China.
P HuThe First Affiliated Hospital of Chongqing Medical University, Chongqing400016, China.
X Q ZhangJiangsu Hansoh Pharmaceutical Group Co., Ltd, Lianyungang 222000, China.
Q J GaoJiangsu Hansoh Pharmaceutical Group Co., Ltd, Lianyungang 222000, China.
C N JinJiangsu Hansoh Pharmaceutical Group Co., Ltd, Lianyungang 222000, China.
C LiJiangsu Hansoh Pharmaceutical Group Co., Ltd, Lianyungang 222000, China.
J Q NiuThe First Hospital of Jilin University, Changchun130021, China.
J L HouKey Laboratory of Infectious Diseases Research in South China, Ministry of Education, Nanfang Hospital, Southern Medical University, Guangzhou510515, China.
TMF Study Group

Funding

National Key Research and Development Program of China 2022YFC2303600Science and Technology Foundation and Application Foundation Research Project in Guangzhou 2023A04J2288
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsHepatitis B, ChronicTenofovirAdultDNA, ViralFemaleHepatitis B virusHumansMaleTreatment OutcomeAntiviral AgentsDNA, ViralTenofovir

Identifiers

PMID39528323
PMCPMC12677290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.